Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marlou P. M. Adriaanse"'
Autor:
Johanna M. Kreutz, Marlou P. M. Adriaanse, Elisabeth M. C. van der Ploeg, Anita C. E. Vreugdenhil
Publikováno v:
Nutrients, Vol 12, Iss 2, p 500 (2020)
Nutrient deficiencies are well recognized as secondary consequences of celiac disease (CD) and closely related to the clinical presentation of affected patients. Despite their clinical significance, consensus is lacking on the pattern and frequency o
Externí odkaz:
https://doaj.org/article/7975ac1531c64f14883494d13d345d2b
Autor:
Marlou P M Adriaanse, Linda J T M van der Sande, Anita M van den Neucker, Paul P C A Menheere, Edward Dompeling, Wim A Buurman, Anita C E Vreugdenhil
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0138062 (2015)
Previous studies have suggested the existence of enteropathy in cystic fibrosis (CF), which may contribute to intestinal function impairment, a poor nutritional status and decline in lung function. This study evaluated enterocyte damage and intestina
Externí odkaz:
https://doaj.org/article/640f99e36b3a44198082de8c7e887f9f
Autor:
Marcel G.J. Tilanus, Lisette Groeneveld, Anita Vreugdenhil, Stefan J. J. Molenbroeck, Véronique Vastmans, Marlou P. M. Adriaanse, Christina E.M. Voorter, Dina A Schott
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:1711-1716
Background and aim Human leukocyte antigen (HLA) typing is an important step in the diagnostic algorithm for celiac disease (CD) and is also used for screening purposes. Collection of blood is invasive and accompanied with emotional impact especially
Autor:
Detlef Schuppan, Jeff Goldsmith, Ciaran P. Kelly, Marlou P. M. Adriaanse, Robert M. Najarian, W.A. Buurman, Daniel A. Leffler, Anita Vreugdenhil
Publikováno v:
American Journal of Gastroenterology, 111(7), 1014-1022. Nature Publishing Group
OBJECTIVES: Response to gluten challenge (GC) is a key feature in diagnostic algorithms and research trials in celiac disease (CD). Currently, autoantibody titers, late responders to GC, and invasive duodenal biopsies are used to evaluate gluten resp
Autor:
Tim G. A. M. Wolfs, Bart de Vries, Joep P. M. Derikx, Reint K. Jellema, Marieke Elst, Marlou P. M. Adriaanse, Kostan W. Reisinger, Peter G. J. Nikkels, Boris W. Kramer
Publikováno v:
Pediatric Research, 76(3), 261-268. Nature Publishing Group
BACKGROUND: Gut immaturity is linked with postnatal intestinal disorders. However, biomarkers to assess the intestinal developmental stage around birth are lacking. The aim of this study was to gain more insight on intestinal fatty acid binding prote
Autor:
Marcel G.J. Tilanus, Christien Voorter, M. Groeneweg, Anita Vreugdenhil, Marlou P. M. Adriaanse, S.J.A.M. Castelijns, C.K. van der Ent, H. T. Brüggenwirth
Publikováno v:
Tissue Antigens. 83:27-31
Cystic fibrosis (CF) is classically attributed to the dysfunction of the single CF transmembrane conductance regulator gene. The incidence of human leukocyte antigen (HLA) polymorphisms in different CF-associated diseases raises the question of an un
Autor:
Wim A. Buurman, Marlou P. M. Adriaanse, K. van Wijck, V. Lima Passos, Chris J. J. Mulder, Marco W.J. Schreurs, G.J. Tack, Robert G. Riedl, Anita Vreugdenhil, Ad A.M. Masclee, Jan Damoiseaux
Publikováno v:
Adriaanse, M P M, Tack, G J, Passos, V L, Damoiseaux, J G M C, Schreurs, M W J, van Wijck, K, Riedl, R G, Masclee, A A M, Buurman, W A, Mulder, C J J & Vreugdenhil, A C E 2013, ' Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies ', Alimentary Pharmacology and Therapeutics, vol. 37, no. 4, pp. 482-490 . https://doi.org/10.1111/apt.12194
Alimentary Pharmacology & Therapeutics, 37(4), 482-490. Wiley
Alimentary Pharmacology and Therapeutics, 37(4), 482-490
Alimentary Pharmacology & Therapeutics, 37(4), 482-490. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics, 37(4), 482-490. Wiley
Alimentary Pharmacology and Therapeutics, 37(4), 482-490
Alimentary Pharmacology & Therapeutics, 37(4), 482-490. Wiley-Blackwell Publishing Ltd
Summary Background Enterocyte damage is the hallmark of coeliac disease (CD) resulting in malabsorption. Little is known about the recovery of enterocyte damage and its clinical consequences. Serum intestinal fatty acid binding protein (I-FABP) is a
Autor:
Wim A. Buurman, Anita M Van den Neucker, Victorien M. Wolters, Roderick H. J. Houwen, Marlou P. M. Adriaanse, Annemarie A. van Bijnen, Anita Vreugdenhil
Publikováno v:
Scandinavian Journal of Gastroenterology, 46(12), 1435-1441. Informa Healthcare
Objectives. Addition of a non-invasive marker for intestinal damage to the currently used parameters for celiac disease activity (symptoms, serologic tests and biopsy) might further improve clinical management of celiac disease (CD). Intestinal fatty
Autor:
Linda J T M van der Sande, Anita Vreugdenhil, Paul P.C.A. Menheere, Anita M Van den Neucker, Wim A. Buurman, Edward Dompeling, Marlou P. M. Adriaanse
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 10, p e0138062 (2015)
PLOS ONE, 10(10):e0138062. Public Library of Science
PLoS ONE, Vol 10, Iss 10, p e0138062 (2015)
PLOS ONE, 10(10):e0138062. Public Library of Science
BACKGROUND: Previous studies have suggested the existence of enteropathy in cystic fibrosis (CF), which may contribute to intestinal function impairment, a poor nutritional status and decline in lung function. This study evaluated enterocyte damage a
Publikováno v:
Digestive diseases (Basel, Switzerland). 33(2)
The advent of highly reliable noninvasive celiac diagnostic tests has transformed the field of celiac disease, from diagnosis, to evaluation of epidemiology, to clinical and translational research. Serologic tests in their modern forms are highly sen